Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Asplin

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
The Journal of Urology|March 27, 2026
Baseline Urinary Calcium and the Efficacy of Thiazide Diuretics for Kidney Stone PreventionRyan S Hsi, Phyllis L Yan, Joseph J Crivelli, et al.
Kidney360|August 11, 2025
Correction to: The Effect of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists on 24-Hour Urine Parameters: A Retrospective Cohort StudyJennifer A Schaub, Mary K Oerline, Joseph J Crivelli, et al.
Kidney360|February 7, 2025
The Effect of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists on 24-Hour Urine Parameters: A Retrospective Cohort StudyJennifer A Schaub, Mary K Oerline, Joseph J Crivelli, et al.
Calcified Tissue International|February 1, 2014
1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming ratsAdeline H Ng, Kevin K Frick, Nancy S Krieger, et al.
Scientific Reports|August 13, 2021
Effect of antibiotic treatment on Oxalobacter formigenes colonization of the gut microbiome and urinary oxalate excretionLama Nazzal, Fritz Francois, Nora Henderson, et al.
Kidney International Reports|December 23, 2017
Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal DiseaseTheresa Ermer, Christoph Kopp, John R Asplin, et al.
Journal of the American Society of Nephrology : JASN|June 18, 2016
Loss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate SecretionFelix Knauf, Robert B Thomson, John F Heneghan, et al.
Gastroenterology|January 17, 2017
Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric BypassAmber M Moreland, Carol A Santa Ana, John R Asplin, et al.
Elife|March 26, 2021
Microbial genetic and transcriptional contributions to oxalate degradation by the gut microbiota in health and diseaseMenghan Liu, Joseph C Devlin, Jiyuan Hu, et al.
Urolithiasis|May 8, 2019
Assessment of conservative dietary management as a method for normalization of 24-h urine pH in stone formersDaniel A Wollin, Leah G Davis, Brenton B Winship, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Urology|March 27, 2026
Baseline Urinary Calcium and the Efficacy of Thiazide Diuretics for Kidney Stone PreventionRyan S Hsi, Phyllis L Yan, Joseph J Crivelli, et al.
Kidney360|August 11, 2025
Correction to: The Effect of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists on 24-Hour Urine Parameters: A Retrospective Cohort StudyJennifer A Schaub, Mary K Oerline, Joseph J Crivelli, et al.
Kidney360|February 7, 2025
The Effect of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists on 24-Hour Urine Parameters: A Retrospective Cohort StudyJennifer A Schaub, Mary K Oerline, Joseph J Crivelli, et al.
Calcified Tissue International|February 1, 2014
1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming ratsAdeline H Ng, Kevin K Frick, Nancy S Krieger, et al.
Scientific Reports|August 13, 2021
Effect of antibiotic treatment on Oxalobacter formigenes colonization of the gut microbiome and urinary oxalate excretionLama Nazzal, Fritz Francois, Nora Henderson, et al.
Kidney International Reports|December 23, 2017
Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal DiseaseTheresa Ermer, Christoph Kopp, John R Asplin, et al.
Journal of the American Society of Nephrology : JASN|June 18, 2016
Loss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate SecretionFelix Knauf, Robert B Thomson, John F Heneghan, et al.
Gastroenterology|January 17, 2017
Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric BypassAmber M Moreland, Carol A Santa Ana, John R Asplin, et al.
Elife|March 26, 2021
Microbial genetic and transcriptional contributions to oxalate degradation by the gut microbiota in health and diseaseMenghan Liu, Joseph C Devlin, Jiyuan Hu, et al.
Urolithiasis|May 8, 2019
Assessment of conservative dietary management as a method for normalization of 24-h urine pH in stone formersDaniel A Wollin, Leah G Davis, Brenton B Winship, et al.
Pageof 10